VENU ALAPATI: Open Payments
NPI 1104239516 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,579 in 77 payments from 14 companies in 2025. Trend: 2023 $1,094 · 2024 $1,994 · 2025 $1,579
Food & beverage: $1,579
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $456 |
| E.R. Squibb & Sons, L.L.C. | 12 | $210 |
| Alkermes, Inc. | 11 | $191 |
| Corium, LLC | 12 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $163 |
| Neurocrine BioSciences, Inc. | 5 | $133 |
| Collegium Pharmaceutical, Inc. | 6 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Noven Therapeutics, LLC | 1 | $22 |
Products named: HETLIOZ, FANAPT, COBENFY, Azstarys, ARISTADA, CAPLYTA, INGREZZA, Jornay PM.
Industry payments across IN — which companies pay providers there.
